Cross Country Healthcare, Inc. (NASDAQ:CCRN) – Oppenheimer Holdings cut their Q4 2017 earnings per share estimates for Cross Country Healthcare in a report issued on Thursday, Zacks Investment Research reports. Oppenheimer Holdings analyst M. Wiederhorn now forecasts that the business services provider will post earnings of $0.19 per share for the quarter, down from their prior forecast of $0.25. Oppenheimer Holdings also issued estimates for Cross Country Healthcare’s Q1 2018 earnings at $0.12 EPS, Q2 2018 earnings at $0.20 EPS and FY2018 earnings at $0.81 EPS.
A number of other equities analysts also recently commented on the stock. Credit Suisse Group assumed coverage on shares of Cross Country Healthcare in a report on Tuesday, November 7th. They issued a “neutral” rating and a $13.00 target price for the company. TheStreet downgraded shares of Cross Country Healthcare from a “b-” rating to a “c+” rating in a report on Friday, November 3rd. BMO Capital Markets cut their price objective on shares of Cross Country Healthcare from $15.00 to $14.00 and set an “outperform” rating on the stock in a report on Monday, November 6th. Cantor Fitzgerald restated a “buy” rating and set a $18.00 price objective on shares of Cross Country Healthcare in a report on Wednesday, November 1st. Finally, Zacks Investment Research downgraded shares of Cross Country Healthcare from a “hold” rating to a “sell” rating in a report on Monday, October 9th. Two analysts have rated the stock with a sell rating, two have issued a hold rating and five have issued a buy rating to the stock. Cross Country Healthcare presently has a consensus rating of “Hold” and a consensus price target of $15.31.
Cross Country Healthcare (CCRN) opened at $12.19 on Monday. The company has a market cap of $445.07, a PE ratio of 19.06, a price-to-earnings-growth ratio of 1.08 and a beta of 0.77. The company has a quick ratio of 2.14, a current ratio of 2.14 and a debt-to-equity ratio of 0.46. Cross Country Healthcare has a fifty-two week low of $11.07 and a fifty-two week high of $16.38.
Cross Country Healthcare (NASDAQ:CCRN) last announced its earnings results on Wednesday, November 1st. The business services provider reported $0.23 EPS for the quarter, topping the Zacks’ consensus estimate of $0.18 by $0.05. The business had revenue of $228.50 million during the quarter, compared to the consensus estimate of $228.97 million. Cross Country Healthcare had a net margin of 0.19% and a return on equity of 11.69%. The firm’s revenue was up 6.3% on a year-over-year basis. During the same period in the previous year, the company posted $0.24 earnings per share.
A number of institutional investors have recently added to or reduced their stakes in the business. Highbridge Capital Management LLC purchased a new stake in Cross Country Healthcare in the 3rd quarter worth approximately $402,000. Cornerstone Capital Management Holdings LLC. boosted its position in Cross Country Healthcare by 37.5% in the 3rd quarter. Cornerstone Capital Management Holdings LLC. now owns 110,700 shares of the business services provider’s stock worth $1,574,000 after purchasing an additional 30,200 shares in the last quarter. Royce & Associates LP boosted its position in Cross Country Healthcare by 8.2% in the 3rd quarter. Royce & Associates LP now owns 857,675 shares of the business services provider’s stock worth $12,205,000 after purchasing an additional 65,211 shares in the last quarter. OxFORD Asset Management LLP boosted its position in Cross Country Healthcare by 137.5% in the 3rd quarter. OxFORD Asset Management LLP now owns 124,906 shares of the business services provider’s stock worth $1,774,000 after purchasing an additional 72,308 shares in the last quarter. Finally, Dimensional Fund Advisors LP boosted its position in Cross Country Healthcare by 12.9% in the 3rd quarter. Dimensional Fund Advisors LP now owns 1,448,727 shares of the business services provider’s stock worth $20,615,000 after purchasing an additional 165,624 shares in the last quarter. Institutional investors and hedge funds own 96.40% of the company’s stock.
In related news, insider William J. Grubbs sold 49,113 shares of the stock in a transaction that occurred on Thursday, August 24th. The shares were sold at an average price of $12.16, for a total value of $597,214.08. Following the transaction, the insider now owns 395,188 shares in the company, valued at approximately $4,805,486.08. The sale was disclosed in a filing with the SEC, which is available through this link. Also, Director Thomas C. Dircks purchased 10,000 shares of the business’s stock in a transaction that occurred on Monday, November 6th. The stock was acquired at an average price of $11.77 per share, for a total transaction of $117,700.00. Following the acquisition, the director now owns 104,571 shares in the company, valued at approximately $1,230,800.67. The disclosure for this purchase can be found here. 3.90% of the stock is currently owned by corporate insiders.
About Cross Country Healthcare
Cross Country Healthcare, Inc is engaged in providing healthcare recruiting, staffing, recruiting and workforce solutions. The Company operates in three segments: Nurse and Allied Staffing, Physician Staffing and Other Human Capital Management Services. The Nurse and Allied Staffing segment provides traditional staffing, including temporary and permanent placement of travel nurses and allied professionals, and branch-based local nurses and allied staffing.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Cross Country Healthcare Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cross Country Healthcare Inc. and related companies with MarketBeat.com's FREE daily email newsletter.